Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129753
Status:
WITHDRAWN
Last Update Posted:
2018-11-08
First Post:
2005-08-11
Brief Title:
Alemtuzumab Campath-1H Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkins Disease
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center